Search

You searched for "screening"

2392 results found

Supporting innovative eye disease research

14 May 2026 | research, private sector
Newmedica is supporting research into a potential next generation treatment for diabetic retinopathy, reinforcing its commitment as an eye health champion. Working in partnership with charity Sight Research UK, the project is led by Dr Michael O’Hare and his team...

NICE drugs: an update on what’s good to go

1 June 2014 | | EYE - Neuro-ophthalmology, EYE - Vitreo-Retinal
Treatment options recommended by the National Institute for Health and Care Excellence (NICE) must be readily available for use in the NHS of England and Wales. This article provides an overview of recent guidance from NICE and summary advice issued...

SOC welcomes registrations and poster submissions for September meeting

27 July 2021
The theme of the Scottish Ophthalmological Club spring meeting on 23 September is ‘Post COVID – The Best of Times and The Worst of Times', featuring eminent speakers on a range of topics.

Forward looking practices to plan for 5 years at 100% Optical

26 January 2024
The OSA is urging practices to adopt a forward-thinking approach and to make investment decisions for a five-year business plan, as the industry and profession meet at 100% Optical 24-26 February.
Pseudophakic Monovision book cover

Pseudophakic Monovision: A Clinical Guide

5 June 2020 | | EYE - Cataract, EYE - Refractive
The contents of this small volume should provide useful tips for all ophthalmic practitioners involved with managing patients undergoing cataract surgery. For those ophthalmic clinicians and supporting staff not familiar with the potential options for achieving a spectacle independent refractive...

My top five: Emerging alternatives to manage and treat nAMD

3 April 2024 | | EYE - Vitreo-Retinal
Wet (exudative or neovascular) age-related macular degeneration (AMD) is characterised by choroidal neovascularisation, in which new blood vessels from the choroid invade through Bruch’s membrane. These blood vessels proliferate beneath or through the retinal pigment epithelium (RPE), causing patients to...

My Top Five: Emerging alternatives to manage and treat nAMD

3 April 2024 | | EYE - General
Wet (exudative or neovascular) age-related macular degeneration (AMD) is characterised by choroidal neovascularisation, in which new blood vessels from the choroid invade through Bruch’s membrane. These blood vessels proliferate beneath or through the retinal pigment epithelium (RPE), causing patients to...

Spotlight: The Community Eye Health Journal

3 August 2023 | | EYE - General
In many low-income settings, where vision loss is greatest, eyecare is hampered by shortages in trained health workers. In sub-Saharan Africa, there are fewer than five ophthalmologists per million population, compared to over 70 per million in high-income countries. Eyecare...

OBITUARY: James Finbarr (Barry) Cullen

16 October 2020 | | EYE - Neuro-ophthalmology, EYE - General
On the sad passing of Eye News’ first editor and long-term contributor JF (Barry) Cullen, his friend Hector Chawla takes a look at the life and career of this effervescent character and giant of the ophthalmology world. Barry Cullen was...

Evolving towards an interventional glaucoma mindset

2 February 2024 | | EYE - Glaucoma
Traditionally, a newly diagnosed glaucoma patient would be treated first with medical therapy. As the disease progressed or the initial intervention failed to adequately control intraocular pressure (IOP), clinicians would add more drops, selective laser trabeculoplasty (SLT), repeated SLT and...

Contemporary glaucoma therapy: spoilt for choice

1 April 2014 | | EYE - Glaucoma
The goal of glaucoma management is to prevent visual loss and disease progression in the patient’s lifetime through effective lowering of intraocular pressure (IOP), the primary modifiable risk factor in glaucoma. Sustained and consistent IOP reduction is key to halting...

Radiation retinopathy

5 June 2020 | | EYE - Vitreo-Retinal, EYE - General
The authors review the current treatment options for this condition. Radiation retinopathy (RR) occurs as a complication after exposure to any type of radiation (external beam, plaque brachytherapy and stereotactic radiosurgery) in the orbital or adnexal region. These include nasopharyngeal...